Glucose Bioluz (Glucose)

Glucose Bioluz is indicated for several clinical situations where rapid carbohydrate delivery and fluid balance are required.

• Treatment of hypoglycemia when oral glucose is not feasible.
• Provision of calories in patients receiving parenteral nutrition.
• Fluid and electrolyte replacement in dehydration or postoperative care.
• Support during surgery or critical illness when enteral feeding is contraindicated.
• Dilution and compatibility with other intravenous medications as directed by clinical protocols.

When administered intravenously, Glucose Bioluz may be associated with a range of adverse effects, which are generally categorized by frequency and severity.

Common

• Mild hyperglycemia observed in patients with limited insulin response.
• Transient nausea or vomiting related to rapid infusion rates.
• Local irritation or pain at the infusion site.
• Electrolyte shifts, particularly mild hyponatremia, due to dilutional effects.

Serious

• Severe hyperglycemia leading to osmotic diuresis and dehydration.
• Hypersensitivity reactions, including rash, urticaria, or anaphylaxis.
• Hyperosmolar hyperglycemic state in susceptible individuals.
• Fluid overload causing pulmonary edema, especially in patients with cardiac dysfunction.

Clinicians should evaluate patient-specific factors before initiating Glucose Bioluz therapy to minimize risks and ensure appropriate use.

• Assess blood glucose levels and adjust infusion rates in diabetic patients.
• Monitor fluid balance and weight to avoid overload in heart or kidney disease.
• Use caution in patients with known hypersensitivity to glucose solutions.
• Verify compatibility with other IV drugs to prevent precipitation or instability.
• Adjust electrolyte supplementation as needed due to dilutional changes.
• Follow aseptic technique to reduce the risk of catheter‑related infections.

Glucose Bioluz can interact with other intravenously administered agents, influencing their efficacy or safety profile.

Avoid

• Co‑administration with high‑dose insulin infusions without glucose monitoring.
• Simultaneous infusion of incompatible solutions such as calcium chloride or certain antibiotics that may precipitate.
• Use with dextrose‑containing parenteral nutrition formulas that could cause excessive carbohydrate load.

Use with caution

• Concurrent administration of diuretics, which may exacerbate electrolyte disturbances.
• Combination with vasopressors, requiring careful monitoring of hemodynamic status.
• Infusion alongside blood products, as glucose may affect cell viability and storage conditions.